The global Farm Animal Healthcare Market was valued at USD 15645.78 million in 2020 and is estimated to reach USD 21600.76 million in 2024, witnessing a CAGR of 6.69%.
Major lead players in the market are Bayer Healthcare, Boehringer Ingelheim, Ceva Animal Health, Elanco, Merck, Merial (Sanofi), Virbac and Zoetis Animal Healthcare.
During this pandemic FDA’s Center for Veterinary Medicine is a microcosm of FDA for animals – They regulate drugs, food, and devices for pets, livestock, zoo animals and others. Although COVID-19 is understood to primarily be a human disease, CVM and its stakeholders are experiencing the impact of the outbreak in other ways. Bayer healthcare addressing in Sept 2020 despite the difficult market environment, the urgent need for innovative healthcare and agriculture solutions has never been more evident. Strategy of building leading businesses in life sciences remains unchanged. They believe the additional measures are necessary to accelerate our overall transformation, generate margin improvements and thus maintain our competitive profile. They will help mitigate the impact of COVID-19 on our business. We must adapt our cost structures to the changes in market conditions and at the same time generate resources for further investment in innovation and growth.
June 2020 Biological Conservation by a scientist from the Institute of Evolution Sciences of Montpellier and the French Agricultural Research Centre for International Development's (CIRAD) ASTRE laboratory publisheed that to overcome the growth of global livestock farming is a threat to our biodiversity and also increases the health risks to both humans and domesticated animals. Farm animals constitute valuable source of quality nutrition and economic development across the world, and sustainable farm animal production is greatly being challenged by pets and disease infestation with the resultant poor conductivity, death of animals and economic losses to the farmers and nations at large.in Europe the livestock sector contributes almost 125 billion Euros per year and accounts for 40% of total agricultural production in the area.
Smallholder farmers in Africa have limited or no access to high quality veterinary medicinal products (VMPs) due to poor distribution channels, low levels of awareness about animal diseases and the way these can be prevented or treated. Boehringer Ingelheim has adopted a business model that addresses those barriers To accelerate the roll-out of the current and future veterinary medicine portfolio, Boehringer Ingelheim deployed groups of animal health technicians (called LastMile Livestock Service Providers, LLSPs) from the local communities in each of our targeted markets to travel around their local regions covering areas which are normally very difficult or impossible to access through usual distribution networks. LLSPs are to check health status of animals at the smallholder farm level, give basic veterinary and herd management advice, demonstrate administering products, and survey/replenish stocks of registered veterinary products at local retails shops.
Market Segmentation of Farm animal Health market based On the basis of product, this report, primarily split into Vaccines, Paraciticides and Anti-Infective, Medicinal Feed Additives other pharmaceuticals. On the basis of the applications, this report focuses on the status and outlook for major applications, including Cattle, Swine, Poultry, Fish, sheep and others. Geographically it splits into North America, Europe, Asia-Pacific and others. North America region is among the major contributor to agriculture, livestock, technological advancements and implementation of farm animal healthcare benefits across the region. In the US, agriculture is an important factor for the country's overall economy. The innovation level of companies and government awareness along with preparedness level for farm animal healthcare are fast compared to other regions.